Antimicrobial treatment of ENT infections

Area of Science:

• Otolaryngology
• Pediatric Infectious Diseases
• Antimicrobial Stewardship

Background:

• Ear, nose, and throat (ENT) infections are highly prevalent in children, driving significant antibiotic prescriptions.
• Many ENT infections, even those with bacterial involvement, are self-limiting, primarily caused by viruses.

Purpose of the Study:

• To provide guidance on judicious antibiotic prescribing for common childhood ENT infections.
• To delineate specific clinical scenarios where antibiotic treatment is indicated versus those requiring watchful waiting.

Main Methods:

• Review of current clinical guidelines and evidence for managing pediatric ENT infections.
• Analysis of diagnostic criteria and treatment recommendations for pharyngitis and otitis media.

Main Results:

• Antibiotics should be avoided for common cold, non-streptococcal pharyngitis, laryngitis, and non-purulent otitis media.
• Group A Streptococcus rapid diagnostic tests guide antibiotic decisions for pharyngitis.
• Antibiotic treatment for otitis media is reserved for purulent forms in children under two and severe cases in older children.
• Amoxicillin is the primary antibiotic choice for treatable ENT infections.
• Severe ENT infections necessitate immediate medical attention, often requiring hospitalization and intravenous antibiotics.

Conclusions:

• Antibiotic overuse for pediatric ENT infections can be reduced by adhering to evidence-based guidelines.
• Accurate diagnosis and risk stratification are crucial for appropriate antibiotic use in childhood ENT infections.
• Focusing antibiotic therapy on severe and confirmed bacterial infections improves outcomes and combats antimicrobial resistance.